Literature DB >> 1776137

Comparative study on the in vitro effectiveness of antithrombotic agents.

E P Pâques1, J Römisch.   

Abstract

The synthetic low molecular weight inhibitors MD 805, FUT-175 and FOY as well as heparin and r-Hirudin were compared for their in vitro antithrombotic potencies and protease specificities. The amidolytic activity of thrombin and the plasma coagulation were effectively inhibited by MD 805 and, in particular, by r-Hirudin. FUT-175 and FOY revealed only weak inhibition. None of the synthetic substances discriminated between alpha-, beta- and gamma-thrombin. Beside r-Hirudin only MD 805 revealed a relatively good specificity for thrombin. On the contrary, FUT-175 and FOY are unspecific and can not be classified as thrombin inhibitors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1776137     DOI: 10.1016/0049-3848(91)90201-7

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  4 in total

1.  Pretreatment with nafamostat mesilate, a kallikrein inhibitor, to decrease withdrawal response associated with rocuronium.

Authors:  Yoon Hee Kim; Young Kwon Go; Jung Un Lee; Woo Suk Chung; Yong Sup Shin; Kyu Cheol Han; Ji Eun Shin; Suk Hoon Lee
Journal:  J Anesth       Date:  2010-05-25       Impact factor: 2.078

2.  Protective effects of nafamostat mesilate on liver injury induced by lipopolysaccharide in rats: possible involvement of CD14 and TLR-4 downregulation on Kupffer cells.

Authors:  Hideaki Miyaso; Yoshinori Morimoto; Michitaka Ozaki; Sanae Haga; Susumu Shinoura; Yasuhiro Choda; Hiroshi Murata; Goutaro Katsuno; Kamul Huda; Hideo Takahashi; Noriaki Tanaka; Hiromi Iwagaki
Journal:  Dig Dis Sci       Date:  2006-10-28       Impact factor: 3.199

3.  Nafamostat mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury.

Authors:  Satoshi Hagiwara; Hideo Iwasaka; Takayuki Noguchi
Journal:  J Anesth       Date:  2007-05-30       Impact factor: 2.078

4.  Measuring the Concentration of Serum Syndecan-1 to Assess Vascular Endothelial Glycocalyx Injury During Hemodialysis.

Authors:  Keigo Kusuzawa; Keiko Suzuki; Hideshi Okada; Kodai Suzuki; Chihiro Takada; Soichiro Nagaya; Ryu Yasuda; Haruka Okamoto; Takuma Ishihara; Hiroyuki Tomita; Yuki Kawasaki; Toru Minamiyama; Ayane Nishio; Hirotsugu Fukuda; Takuto Shimada; Yuto Tamaoki; Tomoki Yoshida; Yusuke Nakashima; Naokazu Chiba; Genki Yoshimura; Ryo Kamidani; Tomotaka Miura; Hideaki Oiwa; Fuminori Yamaji; Yosuke Mizuno; Takahito Miyake; Yuichiro Kitagawa; Tetsuya Fukuta; Tomoaki Doi; Akio Suzuki; Takahiro Yoshida; Nobuyuki Tetsuka; Shozo Yoshida; Shinji Ogura
Journal:  Front Med (Lausanne)       Date:  2021-12-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.